HEWA Quote, Financials, Valuation and Earnings

Nowtransit has a net margin of 0.82% compared to HealthWarehouse.com's net margin of 9.81%. HealthWarehouse.com's return on equity of -- beat Nowtransit's return on equity of 28.6%.

HealthWarehouse.com has a consensus price target of --, signalling upside risk potential of 766.67%. On the other hand Nowtransit has an analysts' consensus of -- which suggests that it could fall by --. Given that HealthWarehouse.com has higher upside potential than Nowtransit, analysts believe HealthWarehouse.com is more attractive than Nowtransit.

HealthWarehouse.com has a beta of 0.194, which suggesting that the stock is 80.56% less volatile than S&P 500. In comparison Nowtransit has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

HealthWarehouse.com has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nowtransit offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthWarehouse.com pays -- of its earnings as a dividend. Nowtransit pays out -- of its earnings as a dividend.

HealthWarehouse.com quarterly revenues are $9M, which are larger than Nowtransit quarterly revenues of $573K. HealthWarehouse.com's net income of $73.8K is higher than Nowtransit's net income of $56.2K. Notably, HealthWarehouse.com's price-to-earnings ratio is -- while Nowtransit's PE ratio is 7,107.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthWarehouse.com is 0.17x versus 350.40x for Nowtransit. Usually stocks with elevated PS ratios are considered overvalued.

Medicine Man Technologies has a net margin of 0.82% compared to HealthWarehouse.com's net margin of -32.23%. HealthWarehouse.com's return on equity of -- beat Medicine Man Technologies's return on equity of -39.36%.

HealthWarehouse.com has a consensus price target of --, signalling upside risk potential of 766.67%. On the other hand Medicine Man Technologies has an analysts' consensus of -- which suggests that it could grow by 6500.83%. Given that Medicine Man Technologies has higher upside potential than HealthWarehouse.com, analysts believe Medicine Man Technologies is more attractive than HealthWarehouse.com.

HealthWarehouse.com has a beta of 0.194, which suggesting that the stock is 80.56% less volatile than S&P 500. In comparison Medicine Man Technologies has a beta of 1.838, suggesting its more volatile than the S&P 500 by 83.805%.

HealthWarehouse.com has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Medicine Man Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthWarehouse.com pays -- of its earnings as a dividend. Medicine Man Technologies pays out -- of its earnings as a dividend.

HealthWarehouse.com quarterly revenues are $9M, which are smaller than Medicine Man Technologies quarterly revenues of $43.2M. HealthWarehouse.com's net income of $73.8K is higher than Medicine Man Technologies's net income of -$13.9M. Notably, HealthWarehouse.com's price-to-earnings ratio is -- while Medicine Man Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthWarehouse.com is 0.17x versus 0.02x for Medicine Man Technologies. Usually stocks with elevated PS ratios are considered overvalued.

SunLink Health Systems has a net margin of 0.82% compared to HealthWarehouse.com's net margin of -6.93%. HealthWarehouse.com's return on equity of -- beat SunLink Health Systems's return on equity of -5.08%.

HealthWarehouse.com has a consensus price target of --, signalling upside risk potential of 766.67%. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that HealthWarehouse.com has higher upside potential than SunLink Health Systems, analysts believe HealthWarehouse.com is more attractive than SunLink Health Systems.

HealthWarehouse.com has a beta of 0.194, which suggesting that the stock is 80.56% less volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.404, suggesting its more volatile than the S&P 500 by 40.425%.

HealthWarehouse.com has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthWarehouse.com pays -- of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.

HealthWarehouse.com quarterly revenues are $9M, which are larger than SunLink Health Systems quarterly revenues of $7.9M. HealthWarehouse.com's net income of $73.8K is higher than SunLink Health Systems's net income of -$549K. Notably, HealthWarehouse.com's price-to-earnings ratio is -- while SunLink Health Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthWarehouse.com is 0.17x versus 0.17x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.

Walgreens Boots Alliance has a net margin of 0.82% compared to HealthWarehouse.com's net margin of 0.95%. HealthWarehouse.com's return on equity of -- beat Walgreens Boots Alliance's return on equity of -24.93%.

HealthWarehouse.com has a consensus price target of --, signalling upside risk potential of 766.67%. On the other hand Walgreens Boots Alliance has an analysts' consensus of -- which suggests that it could grow by 8.45%. Given that HealthWarehouse.com has higher upside potential than Walgreens Boots Alliance, analysts believe HealthWarehouse.com is more attractive than Walgreens Boots Alliance.

HealthWarehouse.com has a beta of 0.194, which suggesting that the stock is 80.56% less volatile than S&P 500. In comparison Walgreens Boots Alliance has a beta of 0.664, suggesting its less volatile than the S&P 500 by 33.636%.

HealthWarehouse.com has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Walgreens Boots Alliance offers a yield of 10.47% to investors and pays a quarterly dividend of $0.25 per share. HealthWarehouse.com pays -- of its earnings as a dividend. Walgreens Boots Alliance pays out -14.59% of its earnings as a dividend.

HealthWarehouse.com quarterly revenues are $9M, which are smaller than Walgreens Boots Alliance quarterly revenues of $36.4B. HealthWarehouse.com's net income of $73.8K is lower than Walgreens Boots Alliance's net income of $344M. Notably, HealthWarehouse.com's price-to-earnings ratio is -- while Walgreens Boots Alliance's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthWarehouse.com is 0.17x versus 0.06x for Walgreens Boots Alliance. Usually stocks with elevated PS ratios are considered overvalued.